搜索结果 | 泌尿系统常见疾病循证医学证据

证据分类

搜索结果

共搜索到7条与Hwang有关的结果

Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia

2020年发布于 Cochrane Database Syst Rev 3卷第3期

Kang T. W. Jung J. H. Hwang E. C. Borofsky M. Kim M. H. Dahm P.

Humans Hyperthermia Induced Lower Urinary Tract Symptoms/etiology Male Middle Aged Prostatic Hyperplasia/complications/*therapy Radiofrequency Therapy Randomized Controlled Trials as Topic Steam Treatment Outcome
文献简介 原文链接
Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

2019年发布于 Cochrane Database Syst Rev 2卷第2期

Hwang E. C. Jung J. H. Borofsky M. Kim M. H. Dahm P.

Aged Aged 80 and over Ejaculation Humans Lower Urinary Tract Symptoms/etiology Male Middle Aged Organ Size Penile Erection Prostate/pathology Prostatic Hyperplasia/complications Quality of Life Retreatment/statistics & numerical data Robotic Surgical Procedures Surgery Computer-Assisted/methods Transurethral Resection of Prostate *Water
文献简介 原文链接
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia

2018年发布于 Cochrane Database Syst Rev 11卷第11期

Pattanaik S. Mavuduru R. S. Panda A. Mathew J. L. Agarwal M. M. Hwang E. C. Lyon J. A. Singh S. K. Mandal A. K.

Adrenergic alpha-Antagonists Drug Therapy Combination Humans Lower Urinary Tract Symptoms Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia Randomized Controlled Trials as Topic
文献简介 原文链接
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

2018年发布于 Cochrane Database Syst Rev 10卷第10期

Hwang E. C. Gandhi S. Jung J. H. Imamura M. Kim M. H. Pang R. Dahm P.

Adrenergic alpha-Antagonists Benzilates Drug Combinations Ethamsylate Humans Indoles Lower Urinary Tract Symptoms Male Naphthalenes Piperazines Plant Extracts Prostatic Hyperplasia Prostatism Quality of Life Randomized Controlled Trials as Topic Sulfonamides Tamsulosin Urological Agents
文献简介 原文链接
Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study

2016年发布于 Yonsei Med J 57卷第2期

Shim S. R. Kim J. H. Chang I. H. Shin I. S. Hwang S. D. Kim K. H. Yoon S. J. Song Y. S.

Adrenergic alpha-1 Receptor Antagonists/*administration & dosage Adrenergic alpha-Antagonists Dose-Response Relationship Drug Humans Male Middle Aged Prostatic Hyperplasia *Quality of Life Sulfonamides/*administration & dosage Tamsulosin Prostatic hyperplasia alpha blockers
文献简介 原文链接
Intravesical gemcitabine for non-muscle invasive bladder cancer

 2021 年发布于 Turk J Urol 53 卷第 6 期

Han M. A. Maisch P. Jung J. H. Hwang J. E. Narayan V. Cleves A. Hwang E. C. Dahm P.

Cystectomy/adverse effects/*methods Disease-Free Survival Follow-Up Studies Humans Incidence Intraoperative Complications/*epidemiology/etiology Length of Stay/statistics & numerical data Neoplasm Recurrence Local/*epidemiology/etiology/prevention & control Randomized Controlled Trials as Topic Urinary Bladder/*injuries/pathology/surgery Urinary Bladder Neoplasms/mortality/pathology/*surgery Bipolar bladder tumors meta-analysis monopolar transurethral resection
文献简介 原文链接
Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy

 2019 年发布于国际泌尿系统杂志 9 卷第 11 期

Hwang E. C. Sathianathen N. J. Imamura M. Kuntz G. M. Risk M. C. Dahm P.

*Biomarkers Tumor Disease Progression Gene Expression Humans Matrix Metalloproteinases/*genetics/metabolism Prognosis Publication Bias Survival Analysis Urinary Bladder Neoplasms/*genetics/metabolism/*mortality/pathology bladder cancer matrix metalloproteinases meta-analysis
文献简介 原文链接

Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia

2020年 发布于 Cochrane Database Syst Rev 3卷 第3期

Kang T. W. Jung J. H. Hwang E. C. Borofsky M. Kim M. H. Dahm P.

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

2019年 发布于 Cochrane Database Syst Rev 2卷 第2期

Hwang E. C. Jung J. H. Borofsky M. Kim M. H. Dahm P.

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia

2018年 发布于 Cochrane Database Syst Rev 11卷 第11期

Pattanaik S. Mavuduru R. S. Panda A. Mathew J. L. Agarwal M. M. Hwang E. C. Lyon J. A. Singh S. K. Mandal A. K.

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

2018年 发布于 Cochrane Database Syst Rev 10卷 第10期

Hwang E. C. Gandhi S. Jung J. H. Imamura M. Kim M. H. Pang R. Dahm P.

Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study

2016年 发布于 Yonsei Med J 57卷 第2期

Shim S. R. Kim J. H. Chang I. H. Shin I. S. Hwang S. D. Kim K. H. Yoon S. J. Song Y. S.

Intravesical gemcitabine for non-muscle invasive bladder cancer

 2021 年 发布于 Turk J Urol 53 卷 第 6 期

Han M. A. Maisch P. Jung J. H. Hwang J. E. Narayan V. Cleves A. Hwang E. C. Dahm P.

Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy

 2019 年 发布于 国际泌尿系统杂志 9 卷 第 11 期

Hwang E. C. Sathianathen N. J. Imamura M. Kuntz G. M. Risk M. C. Dahm P.

2020年发布于 Cochrane Database Syst Rev 3卷第3期

2019年发布于 Cochrane Database Syst Rev 2卷第2期

2018年发布于 Cochrane Database Syst Rev 11卷第11期

2018年发布于 Cochrane Database Syst Rev 10卷第10期

2016年发布于 Yonsei Med J 57卷第2期

 2021 年发布于 Turk J Urol 53 卷第 6 期

 2019 年发布于国际泌尿系统杂志 9 卷第 11 期